Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Broadcom today announced Symantec CBX, a cloud-based platform that combines the best Symantec and Carbon Black technologies in one intuitive solution.
-
The XDR Market grows as enterprises adopt advanced cybersecurity platforms to detect, analyze, and respond to threats across endpoints and the cloud.
-
The ESET PROTECT console plugin for ConnectWise Asio opens up more options for MSPs.This integration empowers MSPs with better tools to perform their most common tasks more easily, saving them time...
-
SAN DIEGO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, announced today that CRN®, a brand of The Channel Company, has named ESET PROTECT Elite a winner in the...
-
VIENNA, Va., Feb. 13, 2025 (GLOBE NEWSWIRE) -- USX Cyber, a leader in AI-driven cybersecurity solutions, today announced the latest evolution of its flagship GUARDIENT™ XDR platform—now integrating...
-
BATAVIA, Ill., Dec. 18, 2024 (GLOBE NEWSWIRE) -- High Wire Networks, Inc. (OTCQB: HWNI), an award-winning global provider of managed cybersecurity, has been engaged to provide its innovative...
-
YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
-
FORT LAUDERDALE, Fla, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Netsurion, a leading provider of Managed Detection & Response (MDR), and Radius Channels, a next-generation distributor empowering MSPs...
-
YONKERS, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
-
YONKERS, N.Y., May 15, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...